Pfizer says its COVID-19 vaccine protects younger teens » EntornoInteligente

Pfizer says its COVID-19 vaccine protects younger teens

pfizer_says_its_covid_19_vaccine_protects_younger_teens.jpg

Entornointeligente.com / Pfizer announced Wednesday that its COVID-19 vaccine is safe and strongly protective in kids as young as 12, a step toward possibly beginning shots in this age group before they head back to school in the fall.

Most COVID-19 vaccines being rolled out worldwide are for adults, who are at higher risk from the coronavirus.

Pfizer’s vaccine is authorised for ages 16 and older.

But vaccinating children of all ages will be critical to stopping the pandemic — and helping schools, at least the upper grades, start to look a little more normal after months of disruption.

In a study of 2,260 U.S. volunteers ages 12 to 15, preliminary data showed there were no cases of COVID-19 among fully vaccinated adolescents compared to 18 among those given dummy shots, Pfizer reported.

It’s a small study, that hasn’t yet been published, so another important piece of evidence is how well the shots revved up the kids’ immune systems.

Researchers reported high levels of virus-fighting antibodies, somewhat higher than were seen in studies of young adults.

Kids had side effects similar to young adults, the company said. The main side effects are pain, fever, chills, and fatigue, particularly after the second dose.

The study will continue to track participants for two years for more information about long-term protection and safety.

Dr Philip J Landrigan of Boston College said the results are encouraging.

“It’s hard to get kids to comply with masking and distancing, so something that gives them hard protection and takes them out of the mix of spreading the virus is all for the good,” said Landrigan, who was not involved in the study.

Pfizer and its German partner BioNTech in the coming weeks plan to ask the US Food and Drug Administration and European regulators to allow emergency use of the shots starting at age 12.

AstraZeneca last month began a study of its vaccine among 6- to 17-year-olds in Britain.

Johnson & Johnson is planning its own paediatric studies. And in China, Sinovac recently announced it has submitted preliminary data to Chinese regulators showing its vaccine is safe in children as young as 3.

Follow The Gleaner on Twitter and Instagram @JamaicaGleaner and on Facebook @GleanerJamaica. Send us a message on WhatsApp at 1-876-499-0169 or email us at  [email protected]  or  [email protected] .

LINK ORIGINAL: Jamaica Gleaner

Entornointeligente.com

URGENTE: Conoce aquí los Juguetes más vendidos de Amazon www.smart-reputation.com

Cafecito Informativo

Smart Reputation

Noticias de Boxeo

Boxeo Plus
Boxeo Plus
Repara tu reputación en Twitter con Smart Reputation
Repara tu reputación en Twitter con Smart Reputation

Adscoins

Smart Reputation

Smart Reputation